Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on KBC GROEP NV. We currently have 3 research reports from 1 professional analysts.
|23Dec16 05:00||GNW||KBC Group: Results of the capital increase of KBC Group NV for the employees and effects on the transparency obligations|
|16Dec16 07:00||GNW||KBC Group: Changes within the Board of Directors of KBC|
|14Dec16 07:00||GNW||KBC Group: KBC discloses new ECB capital requirements|
|02Dec16 05:00||GNW||KBC Group: Publication of a transparency notification|
|17Nov16 07:00||GNW||KBC Group: information regarding the traditional annual capital increase reserved for staff|
|17Nov16 06:00||GNW||KBC Group: Strong third-quarter profit of 629 million euros.|
|07Sep16 07:00||GNW||KBC Group: the 1H2016 half-year report of KBC IFIMA is available on kbc.com|
Frequency of research reports
Research reports on
KBC GROEP NV
KBC GROEP NV
Quite reassuring on the net interest margin...
12 May 16
KBC released its Q1 16 earnings this morning. Revenues are well above expectations whereas costs acted as a drag on the bottom-line. With impairments at -€28m, or €80m lower than expectations, profit before tax is 18% higher than consensus. Even if the fully-loaded common equity tier 1 ratio is 30bp lower than last quarter, it is still comfortably above the required 11.25% (in 2018).
Fears on net interest margin...
18 Feb 16
The Q4 15 results were quite disappointing on the P&L side. Revenues were in line with expectations while expenses and impairments were below expectations respectively due to bank taxes and goodwill impairments. On the solvency side, the CET1 ratio is comfortably above the 11.25% required (at 14.9%) after the reimbursement of the €2bn state aid (plus the expected €1bn penalty).
Capital generation is going on...net banking income a bit disappointing
16 Nov 15
KBC released its Q3 15 earnings. Net banking income is in line with expectations (at €1.73bn). Both cost of risk and expenses are better than expected, amounting respectively to -€49m vs -€98m and -€862m vs -€894m. All in all, PBT is 10% higher than expectations.
Making Mobiles Better
17 Jan 17
Mobile phones are increasingly the key connection for the modern world. This means that the performance of mobile phones, and their networks, is going to become more critical for all the apps and businesses that rely on them. New technologies such as VR, AR, and AV will need better, more reliable connections to really move into the mainstream. In this thematic piece we attempt to identify some of the most important issues facing mobile phone networks and their users, and start to identify solutions and enablers that will solve these problems and create value by doing so.
N+1 Singer - Morning Song 19-01-2017
19 Jan 17
ACTUAL EXPERIENCE PLC (ACT LN) | BAGIR GRP LTD (BAGR LN) | BIOQUELL (BQE LN) | BROWN(N.)GROUP (BWNG LN) | CARADOR INCOME FUND PLC (CIFU LN) | HALFORDS GROUP (HFD LN) | NCC GROUP (NCC LN) | ST IVES PLC (SIV LN) | SUMMIT THERAPEUTICS PLC (SUMM LN) | WILMINGTON PLC (WIL LN)
Small Cap Breakfast
19 Jan 17
SuperAwesome — The London based specialist in e-compliance is considering an IPO in its home town according to City A.M. Eco (Atlantic) Oil & Gas—TSX-V listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise. Diversified Gas & Oil—According to LSE website first day of trading on AIM now expected for 30 January
N+1 Singer - Best Ideas 2017 - Top picks
04 Jan 17
Today we publish our Best Ideas for 2017 - 12 stocks that we believe have excellent prospects in the current year together with a detailed discussion of what we see as the key sector and market themes for 2017. Our top picks are Cineworld, Elementis, Herald Investment Trust, Hill & Smith, IQE, MySale, Redde, ReNeuron, RhythmOne, SDL, Servelec and Severfield.
N+1 Singer - Harwood Wealth - FY16 EBITDA 11% ahead, positive strategic progress
24 Jan 17
Harwood Wealth (“HW”) has delivered final results which showed EBITDA 11% ahead of our forecasts and successful execution of the consolidation strategy with 17 acquisitions in FY16 using IPO proceeds. The board has declared a maiden final dividend of 2p (payable in May) from cash generation. £10.5m net cash leaves the business well positioned to continue to pursue acquisition opportunities. Based on previous multiples paid, we estimate HW has cash resources to materially increase EBITDA complemented by organic growth. HW reports a positive start to FY17e.
N+1 Singer - Northern lights - Shining prospects for 2017
16 Jan 17
As the birthplace of Stephenson, Armstrong and Swan, the North East of England has a proud history of industrial and technological innovation. Despite local economic challenges, the region’s industrial heritage lives on through continuing success in high end engineering and technology. The recent takeovers of private equity backed SMD (subsea robotics) and Nomad Digital (wi-fi on the railways) are testament to this. The North East has also emerged as a leader in genetics and genomics with an enviable life sciences and healthcare infrastructure. Against this backdrop, we expect the region to continue to throw up attractive IPO candidates to build on the six new listings in the past three years. We expect 2017 to be far kinder to the existing portfolio of North East plcs than 2016 (a year to forget) with recent management changes one important theme for the new year. Our top picks are Hargreaves Services, Quantum Pharma and Zytronic (all N+1 Singer Corporate clients) and we are Buyers of Northgate and Grainger.